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Molecular Dynamics simulationsG protein Coupled Receptors (GPCRs) are allosteric proteins whose functioning fundamentals are the
communication between the two poles of the helix bundle. The representation of GPCR structures as networks
of interacting amino acids can be a meaningful way to decipher the impact of ligand and of dimerization/
oligomerization on themolecular communication intrinsic to the protein fold. In this study, we predicted likely
homodimer architectures of the A2AR and investigated the effects of dimerization on the structure network and
the communicationpaths of themonomeric form. The results of this study emphasize the roles of helix 1 inA2AR
dimerization andof highly conserved aminoacids in helices 1, 2, 6 and7 inmaintaining the structurenetwork of
the A2AR through a persistent hub behavior as well as in the information ﬂow between the extracellular and
intracellular poles of the helix bundle. The arginine of the conserved E/DRYmotif, R3.50, is not involved in the
communication paths but participates in the structure network as a stable hub, being linked to both D3.49 and
E6.30 like in the inactive states of rhodopsin. A2AR dimerization affects the communication networks intrinsic
to the receptor fold in a way dependent on the dimer architecture. Certain architectures retain the most
recurrent communication paths with respect to the monomeric antagonist-bound form but enhancing path
numbers and frequencies, whereas some others impair ligand-mediated communication networks. Ligand
binding affects the network as well. Overall, the communication network that pertains to the functional
dynamics of a GPCR is expected to be inﬂuenced by ligand functionality, oligomeric order and architecture of
the supramolecular assembly. This article is part of a Special Issue entitled: “Adenosine Receptors”.osine Receptors”.
+39 059 37353.
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G protein coupled receptors (GPCRs) comprise the largest family of
signal transducingproteins that account for up to 40%of the total targets
for existing drugs (reviewed in [1]). Emerging evidence suggests that
many GPCRs exist as homo- and/or hetero-assemblies of two or more
monomers [2–4]. The A2A-adenosine receptor (A2AR) is not an
exception, as the existence of A2AR homo-dimers at the cell surface
was demonstrated by time-resolved Fluorescence energy transfer
(FRET) [5]. It was, indeed, found that although agonist activation of
the receptor leads to the formation of receptor clusters, it does not affect
the degree of A2AR dimerization. This and other evidences suggested
that homo-dimers are the functional forms of the receptor present on
the plasma membrane [5]. A deletion mutant of the A2AR, lacking its C-
terminal domain was also able to form both monomeric and dimeric
species when extracts from transfected cells were analyzed by
immunoblotting, suggesting that the C-terminal tail of A2AR does not
participate in homo-dimerization [5].In spite of the evidence that rhodopsin and the β2-adrenergic
receptor (β2-AR) activate their cognate G protein in the monomeric
form [6–8] and that supramolecular organizations of rhodopsin [6] and
neurotensin 1 receptor [9] reduceGprotein coupling, formation of GPCR
oligomers in living cells has beenwidely demonstrated [10–12]. Indeed,
it was recently inferred that the β2-AR exists in dynamic equilibrium
between monomers and higher-order oligomers, with the average size
of the oligomer being a tetramer and with inverse agonists promoting
higher-order oligomerization [10]. The occurrence of oligomeric
complexes involving GPCRs and intracellular and extracellular proteins
would imply that receptor conformational changes in response to ligand
may be transmitted to other receptor molecules within the multimo-
lecular complex. The conformational changes transmitted by direct
protein–protein interactions may constitute a ﬁrst level of regulation of
a receptor. In addition to raising fundamental questions about GPCR
function, the concept of dimerization could be important in the
development and screening of drugs that act through supramolecular
assemblies of receptors. In particular, changes in ligand binding and
signaling properties that accompany hetero-dimerization could give
rise to anunexpectedpharmacological diversity. SinceGPCRheteromers
have different characteristics with respect to the constituting receptors,
they provide useful tools for understanding receptor function and
pharmacology [2,13,14]. As a result, novel therapies based on GPCR
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of bivalent ligands [12,15,16].
The biological role(s) of homologous and heterologous receptor
aggregation is/are, however, far from being clariﬁed [14,17,18].
Likewise, knowledge about the most likely architectures of GPCR
dimers is still ill-deﬁned. Sequence-based and docking-based
approaches investigated dimerization in different GPCRs highlighting
the involvement of different helices in the inter-monomer interfaces,
with emphasis to helix 4 (H4) [19]. System's dependent variedness in
the dimer architecture emerges also from the results of in vitro
experiments [20–26]. Collectively, consensus emerges on H1 and H4
being involved in GPCR dimerization/oligomerization.
We have developed a computational approach for predicting the
supramolecular organization of membrane proteins [27] including a
number of GPCRs [28–30]. In this study, such approach served to predict
likely architectures of A2AR homo-dimers. Molecular Dynamics (MD)
simulations on three selected dimers combined with Protein Structure
Network (PSN) analysis was instrumental in investigating the effects of
homo-dimerization on the structural network concerning the mono-
mer. The representation of protein structures as networks of interac-
tions between amino acids has proven to be useful in a number of
studies, suchasprotein folding [31], residue contribution to theprotein–
protein binding free energy in given complexes [26], and prediction of
functionally important residues in enzyme families [32]. This is the ﬁrst
report, in which PSN analysis served to study the effects of dimerization
on the molecular communication characterizing a GPCR.
2. Methods
2.1. Quaternary structure predictions
Rigid-body docking simulations were carried out by means of the
ZDOCK 2.1 software [33], following the same protocol detailed in a
methodological article [27]. In synthesis, dockingwas carried out on two
identical copies of the A2AR monomer, i.e., one monomer was used as a
ﬁxed protein (target) and the other as a mobile protein (probe). The
crystal structure of the A2AR deprived of the T4 lysozyme (PDB 3EML)
[34] was used as a monomer. A rotational sampling interval of 6° was
employed, i.e., dense sampling, and the best 4000 solutions were
retained and ranked according to the ZDOCK score (ZD-score). These
solutions were subjected to a ﬁlter, i.e., the “membrane topology” ﬁlter,
which discards all the solutions characterized by a deviation angle from
the original z-axis, i.e., tilt angle, and a displacement of the geometrical
center along the z-axis, i.e., z-offset, above deﬁned threshold values. For
the tilt angle and the z-offset, thresholds of 0.4 rad and 6.0 Å were,
respectively, employed. The ﬁltered solutions from each run were
merged with the target protein, leading to an equivalent number of
dimers that were subjected to cluster analysis, by using a 2.5 Å Cα-Root
MeanSquareDeviation (RMSD) threshold for eachpair of superimposedN-ter I M G
H1 S S V Y I T V E L A I A V L A I L G N
I1 N S N L Q N V
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Fig. 1. Amino acid sequence of human A2AR. The amino acids conserved in more than 65% o
either one of the three predicted dimers are in bold.dimers. All the amino acid residues in the dimer were included in Cα-
RMSD calculations. This analysis led toprediction of three dimers,which
were manually adjusted to relieve bad contacts.
2.2. MD simulations
The predicted dimers and the monomeric form of the A2AR in
complex with the ZM241385 (ZMA) antagonist were subjected to
energyminimizations and 10 ns ofMD simulations in all-atommode by
using the GBSW implicit membrane/water model [35] implemented in
the CHARMM package [36]. As for dimers, monomers A and B were
treated equally in that they both held the ligand. MD simulations were
carried out on the ligand-free form of monomeric A2AR as well. The
simulated A2AR sequence comprises the last three amino acids from the
N-term (i.e., the 3–5 sequence), the seven helices (H), the three
intracellular and three extracellular loops (I1, I2, I3 and E1, E2, E3,
respectively) and the H8portion of the C-tail (Fig. 1). Those segments in
E2 and I3 that were absent in the crystal structure (i.e., 149–155 and
209–221, respectively) were modeled by using the “LOOP” routine
within theMODELLER software [37]. Minimizationswere carried out by
using 1500 steps of steepest descent followed by Adopted Basis
Newton–Raphson (ABNR) minimization, until the root mean square
gradientwas less than0.001 kcal/mol Å.With respect to the setupofMD
simulations, the lengths of the bonds involving the hydrogen atoms
were restrained by the SHAKE algorithm, allowing for an integration
time step of 0.002 ps. The systemswere heated to 300 Kwith 7.5 K rises
every 2.5 ps per 100 ps, by randomly assigning velocities from a
Gaussian distribution. After heating, the system was allowed to
equilibrate for 100 ps. The temperature of the systems was kept
constant during the 10 ns production phase. The system's degrees of
freedom were reduced by using intra-helix distance restraints with a
scaling factor of 10 and a force constant at 300 K of 10 kcal/mol Å. To
avoid large deviations from the crystallographic binding mode of the
ZMA ligand, distance restrains were applied as well between one
atom from the each of the following binding site amino acids, i.e., F168,
E169 (both in E2), M177(5.38), L249(6.51), H253(6.55), H264 (in E3) and
Y271(7.36), and a selected atoms from the ligand.
2.3. PSN analysis and search for communication paths
PSN and search for communication paths were carried out bymeans
of the PSN module implemented in an updated version of our Wordom
software that is close to being released [38]. The PSNmodule is based on
the approach described in relevant papers by Vishveshwara and co-
workers, which deﬁnes Protein Structure Network as a product of graph
theory applied to protein structures [39]. A graph is deﬁned by a set of
points (nodes) and connections (edges) between them. In a protein
structure graph (PSG), each amino acid is represented as a node and
these nodes are connected by edges based on the strength of non-5
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f GPCR sequences are underlined [43]. Amino acids that participate in the interface in
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between residues i and j (Iij) is evaluated as a percentage givenbyEq. (1):
Iij =
nijﬃﬃﬃﬃﬃﬃﬃﬃﬃ
NiNj
q × 100 ð1Þ
where Iij is the percentage interaction between residues i and j; nij is the
number of atom–atom pairs between the side chains of residues i and j
within a distance cutoff (4.5 Å); Ni and Nj are normalization factors for
residue types i and j, which take into account the differences in size of the
side chains of the residue types and their propensity to make the
maximum number of contacts with other amino acid residues in protein
structures. The normalization factors for the 20 amino acids in our
implementationwere taken from thework byKannan andVishveshwara
[41],whereas thenormalizationvalue for theZMAantagonist, i.e., 139.00,Fig. 2. Predicted A2AR dimers. Two views of the predicted dimers H1–H1/H2–H2 (i.e., DIM1)
and C, respectively. In the left side views receptors are seen from the intracellular side in a di
are seen in a direction parallel to the membrane surface with the cytosolic side on top. H1,
violet. The N-terminal and H8 are red; I1 and E1 are light green; I2 and E2 are gray, and I3 an
receptor portions that participate the most in the interface.was computed as the number of contacts done by the molecule in the
crystal structure of the A2AR [34].
Thus, Iij are calculated for all nodes, excluding i±n,wheren is a given
neighbor cutoff of 2. An interaction strength cutoff Imin is then chosen
and any residue pair ij for which Iij≥ Imin is considered to be interacting
and hence is connected in the PSG. Therefore, it is possible to obtain
different PSGs for the same protein structure depending on the selected
Imin, and, consequently, Imin can be varied to obtain graphs with strong
or weak interactions forming the edges between the residues. The
residues making zero edges are termed as orphans and those thatmake
four or more edges are referred to as hubs at that particular Imin. The
deﬁnition of Iij for evaluating the hub character of a residue is slightly
different from that given in Eq. (1):
Iij =
nij
Ni
× 100 ð2Þ, H1–H4/H2–H2 (i.e., DIM2) and H6–H6,H7/H6–H7 (i.e., DIM3) are shown in panels A, B
rection perpendicular to the membrane plane, whereas in the right side views receptors
H2, H3, H4, H5, H6 and H7 are, respectively, blue, orange, green, pink, yellow, cyan and
d E3 are magenta. The ZMA ligand is represented as black sticks. Numbers indicate the
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residue i whose hub behavior is being evaluated.
Node inter-connectivity is ﬁnally used to highlight cluster-forming
nodes, where a cluster is a set of connected amino acids in a graph.
Node clusterization procedure is such that nodes were iteratively
assigned to a cluster if they could establish a link with at least one
node in such a cluster. A node not linkable to existing clusters initiates
a novel cluster and so on until the node list is exhausted. Cluster size,
deﬁned as the number of nodes, varies as a function of the Imin, and the
size of the largest cluster is used to calculate the Icritic value. The latter
is deﬁned as the Imin at which the size of the largest cluster is half the
size of the largest cluster at Imin=0.0%. At Imin= Icritic weak node
interactions are discarded, emphasizing the effects of stronger
interactions on PSN properties.
In this study, a maximum interatomic distance cutoff of 4.5 Å was
employed to deﬁne the atom contact pairs contributing to the non-
covalent pairwise interaction. Only the atoms constituting the amino
acid side chains as well as the amino and carboxy terminal groups
were considered for the calculation of the interaction strengths. PSN
analyses were carried out at Imin equal to 3.5%, which is equal to the
Icritical (i.e., 3.5%).
All possible shortest communication paths connecting extracellu-
lar and intracellular halves of the targetedmonomerwere searched by
combining PSN data with cross-correlation of atomic ﬂuctuations
calculated by using the Linear Mutual Information (LMI) method [42].
Residues belonging to the extracellular side (i.e., residues ranges: 3–
15, 59–85, 132–189 and 245–277) were tested against residues
belonging to the intracellular side (residues ranges: 23–48, 96–128,
196–239 and 283–310), leading to 17,161 extra/intracellular residue
pairs. Following calculation of the PSN-based connectivities and of
correlated Cα-atom motions, for each frame, the procedure to search
for the shortest path(s) between each residue pair consisted of a)
searching for the shortest path(s) between each selected amino acid
pair based upon the PSN connectivities and b) selecting the shortest
path(s) that contains at least one residue correlated (i.e., with a LMI
cross-correlation ≥0.3) with either one of the two extremities (i.e.,
the ﬁrst and last amino acids in the path). Once the shortest paths
have been found, calculation of the path frequencies, i.e., number of
frames containing the selected path divided by the total number of
frames in the trajectory, is done.
The relative number of amino acids holding correlated motions
with either one of the two extremities is quantiﬁed by the correlation
score, i.e., the ratio between the number of correlated amino acids and
the path length. The latter excludes the two extremities.
Path search saved all the shortest paths with frequencies ≥10%
and length ≥3.Table 1
Amino acids involved in inter-monomer interfaces in the three predicted dimers (DIM1, DI
Regiona DIM1 DIM2
H1, I1 S6(1.32), S7(1.33), I10(1.36), T11(1.37), L14(1.40),
V18(1.44) I21(1.47), L22(1.49), V25(1.51), W29(1.55),
W32(1.58), L33(1.59), Q38
S6(1.32), S7(1.33), I10(1.36), T11(1
A17(1.43), I21(1.47), L22(1.48), V2
L33(1.59), Q38
H2, E1 Y43(2.41), V46(2.44), I53(2.51), V57(2.55), L58(2.56),
P61(2.59), F62(2.60), I64(2.62), T65(2.63), T68, F70
Y43(2.41), V46(2.44), I53(2.51), A5
I60(2.58), P61(2.59), F62(2.60), I64(
H3 H75(3.23), F79(3.27), I80(3.28), F83(3.31) H75(3.23), F79(3.27), I80(3.28), F83
H4, E2 K122(4.43) T119(4.40), R120(4.41), K122(4.43
W129(4.50), V130(4.51), F133(4.54
L141(4.62), N144, P149, N154, Q
H5
H6
H7
H8 I302(8.57), H306(8.61), R309(8.64) I302(8.57), H306(8.61), V307(8.62)
a Receptor regions participating in inter-monomer interfaces in the three predicted dime3. Results
3.1. A2AR is predicted to homo-dimerize through three alternative interfaces
Likely homo-dimers of the A2AR were predicted by a computational
approach based upon rigid-body docking, ad hoc ﬁltering, automatic
cluster analysis and visual inspection of the cluster centers (i.e., the
structure with the highest number of neighbors in a cluster) [27].
Docking solutions that passed the membrane topology-based ﬁlter
(i.e., the realistic solutions) were 29 out of the retrieved 4000 (i.e., only
0.72% of the total output solutions). Cluster analysis separated these
solutions into 6 almost equi-populated clusters. The docking poses
selected as the most reliable, i.e., DIM1, DIM2 and DIM3 belonged to
clusters 5, 4 and 3, respectively (Fig. 2). All the three dimers were
symmetrical in thatmonomersA andB contributed to the interfacewith
almost the same amino acids involved in similar inter-monomer
interactions. In detail, DIM1 is essentially characterized by contacts
between: a) the extracellular ends of H1 and H3; b) the cytosolic end of
H1; and c) theextracellularhalf ofH2(Fig. 2AandTable 1). A variationof
DIM1 is represented by DIM2, which is essentially characterized by
contacts between: a)H1 andH4; b) the extracellular ends of H2 andH3;
and c) the extracellular half of H2 (Fig. 2B and Table 1). Finally, DIM3 is
essentially characterizedby contacts between: a) the cytosolic half ofH6
from monomer A and the cytosolic halves of both H6 and H7 from
monomerB, andviceversa; b) theextracellularhalvesofH6andH7; and
c)H8 and both I3 and the cytosolic extension of H6 (Fig. 2C and Table 1).
Based upon the regions that contribute the most to the three different
interfaces, DIM1, DIM2 and DIM3 can be, respectively, indicated as H1–
H1/H2–H2, H1–H4/H2–H2 and H6–H6/H6–H7 dimers.
As expected, the amino acids that contribute the most to the
predicted interfaces are hydrophobic/aromatic and hold very low
conservation (Fig. 1 and Table 1). An exception is represented by
W129(4.50), which participates in the interface concerning DIM2 and is
almost fully conserved in the rhodopsin family of GPCRs [43].
3.2. A2AR dimerization and ligand binding affect the dynamic distribution
of links and nodes and the way they communicate each other in the
structure network of the monomer
3.2.1. Analysis of hub distribution
In this study, PSN analysis was aimed at highlighting changes in the
dynamic aminoacid connectivities inmonomeric A2AR asa consequence
of differential dimerization. This was accomplished by comparing the
PSNof the A2AR-ZMA complex simulated alone (i.e.,MONO)with that of
the same complex in three different dimer architectures (i.e., DIM1,
DIM2 and DIM3). The effects of ZMA binding on the amino acidM2 and DIM3).
DIM3
.37), L14(1.40), V18(1.44),
5(1.51), W29(1.55), W32(1.58),
4(2.52), V57(2.55), L58(2.56),
2.62), T65(2.63), T68(2.66), F70
(3.31)
), I125(4.46), A126(4.47),
), L137(4.58), M140(4.61),
163
F201(5.62)
R222(6.24), S223(6.25), H230(6.32), K233(6.35), S234(6.36),
I237(6.39), L241(6.43) , L244(6.46), P248(6.50), I251(6.53),
I252(6.54), F255(6.57), F258(6.60)
W268(7.33), L269(7.34), L272(7.37), L276(7.41), I278(7.43),
T279(7.44), F286(7.51), I287(7.52), Y290(7.55), R291(7.57)
, R309(8.64) R296(8.51), Q297(8.52), R300(8.55), K301(8.56), R304(8.59),
Q310(8.65)
rs.
Table 2
Hub frequencies in the ﬁve simulated systems.
Huba Locb MONOAPOc MONOc DIM1c DIM2c DIM3c
Y9 H1 24.29 34.39 36.45 13.27 17.91
E13 H1 97.57 54.15 99.13 55.53 0.01
N24* H1 79.81 53.42 89.93 52.05 2.03
L37 I1 64.06 75.39 75.18 83.95 50.95
N42 H2 9.51 18.81 25.74 47.27 4.81
F44 H2 44.30 21.19 28.74 33.37 21.53
D52* H2 84.07 90.55 90.68 98.27 93.35
F70 E1 0.00 0.15 46.27 0.04 0.00
F83 H3 40.71 27.61 47.08 71.16 6.87
L85 H3 9.06 9.74 13.13 0.98 39.22
Q89 H3 72.05 60.54 63.61 77.63 72.23
L95* H3 52.17 30.40 41.61 47.27 75.41
I98 H3 33.04 12.93 8.18 22.26 17.89
D101* H3 9.42 6.21 38.36 2.77 25.06
R102* H3 13.79 13.78 11.27 56.18 50.44
Y112 I2 5.84 13.12 10.98 9.86 67.82
P139 H4 46.21 28.92 47.52 24.01 34.14
N145 E2 73.80 1.87 1.19 0.03 0.26
Q148 E2 32.44 0.00 0.00 0.00 0.00
K150 E2 51.16 1.64 26.48 0.41 41.96
F168 E2 25.63 18.05 37.16 11.38 32.34
E169 E2 4.56 7.39 5.93 23.56 76.46
V171 E2 4.58 35.17 11.43 0.31 19.13
P173 E2 0.00 26.95 29.35 0.00 30.17
M174 H5 25.59 38.28 44.47 79.47 56.64
Y176 H5 65.58 75.45 80.26 57.38 79.54
M177 H5 33.15 62.55 79.13 80.43 81.89
N181 H5 34.20 33.55 67.96 57.64 84.62
M193 H5 59.15 49.11 24.24 48.51 39.13
Y197* H5 48.79 27.09 8.77 43.62 36.57
R205 H5 1.58 0.00 30.53 0.00 0.00
Q226 H6 0.07 1.39 0.07 32.29 0.46
K227 H6 0.01 4.26 0.78 42.15 0.00
L235 H6 33.49 10.16 4.76 60.56 23.37
I238 H6 47.23 29.75 25.56 2.78 39.63
F242* H6 26.66 42.11 58.52 60.14 53.53
W246* H6 68.48 73.55 84.26 84.19 66.13
H250 H6 7.10 42.64 57.50 49.21 54.49
N253 H6 33.91 30.63 52.66 68.92 35.01
M270 H7 6.26 4.92 4.19 30.08 0.01
Y271 H7 2.74 6.51 13.85 36.30 54.38
I274 H7 31.09 9.38 32.32 11.26 3.63
H278 H7 53.30 25.62 52.58 51.76 16.92
N280* H7 81.66 80.94 66.24 69.26 96.76
N284* H7 94.03 72.16 83.22 32.44 99.37
Y288* H7 79.13 92.18 86.51 75.89 88.14
E294 H8 1.97 11.59 12.61 7.62 33.07
F295* H8 42.79 24.34 34.28 50.20 9.28
ZMA – 0.00 100.00 100.00 100.00 100.00
a Hubs holding frequencies ≥30% in at least one of the ﬁve simulated systems.
Asterisks mark amino acid residues conserved in≥65% of aligned GPCR sequences [43].
b Receptor portion holding the hub.
c Hub frequency, i.e., number of trajectory frames holding the considered hub
divided by the total number of frames (10,000).
Table 3
Protein structure network data.
Network Data MONOAPO MONO DIM1 DIM2 DIM3
Hubsa 28 21 28 31 29
Nodestotb 197 171 160 170 168
Nodescomb 153 (77.66) 137 (85.63) 139 (81.76) 134 (79.76)
Nodesspecb 44 (22.34) 23 (14.38) 31 (18.24) 34 (20.24)
Linkstotcc 255 223 216 228 221
Linkscomc 157 (61.57) 150 (69.44) 149 (65.35) 131 (59.28)
Linksspecc 98 (38.43) 66 (30.56) 79 (34.65) 90 (40.72)
HubLinkstotd 108 81 111 123 113
HubLinkscomd 54 (50.00) 70 (63.06) 65 (52.85) 59 (52.21)
HubLinksspecd 54 (50.00) 41 (36.94) 58 (47.15) 54 (47.79)
Pathstote 840 579 776 955 219
Lengthmaxf 12 11 15 12 9
Freqmaxg 47.75 55.26 56.55 69.89 85.96
Paths30h 78 (9.28) 44 (7.59) 37 (4.77) 89 (9.32) 32 (14.61)
PathsW246-30i 37 (47.43) 40 (90.90) 34 (91.89) 80 (89.89) 7 (21.87)
PathsZMA-30j 24 (54.54) 16 (43.24) 46 (51.68) 0
Paths30-5k 46 (58.97) 28 (63.64) 22 (59.46) 63 (70.79) 0
PathsZMA-30-5l 24 (85.71) 16 (72.72) 46 (73.01) 0
a Number of hubs found in≥30% of the 10,000 trajectory frames (i.e., with frequency
≥30%) concerning the targeted monomer simulated in its isolated state (MONOAPO and
MONO) and in the three different dimer architectures (DIM1, DIM2 and DIM3).
b Data concerning nodes that constitute the largest cluster with frequency ≥30%.
Nodestot is the total number of nodes. Nodescom is the number of nodes that the
targeted monomer in the MONOAPO, DIM1, DIM2 and DIM3 forms shares in common
with the MONO form. Nodesspec is the number of nodes peculiar to the targeted
monomer in the MONOAPO, DIM1, DIM2 and DIM3 forms. The numbers in parenthesis
are the percentages with respect to Nodestot.
c Data concerning links that constitute the largest cluster with frequency ≥30%.
Linkstot is the total number of nodes. Linkscom is the number of links that the targeted
monomer in the MONOAPO, DIM1, DIM2 and DIM3 forms shares in common with the
MONO form. Linksspec is the number of links peculiar to the targeted monomer in the
MONOAPO, DIM1, DIM2 and DIM3 forms. The numbers in parenthesis are the
percentages with respect to Linkstot.
d Data concerning links connecting hubs with frequency ≥30%. “HubLinkstot” is the
total number of links that involve hubs. HubLinkscom is the number of hub-involving
links that the targeted monomer in the MONOAPO, DIM1, DIM2 and DIM3 forms shares
in common with the MONO form. HubLinksspec is the number of hub-involving links
peculiar to the targeted monomer in the MONOAPO, DIM1, DIM2 and DIM3 forms. The
numbers in parenthesis are the percentages with respect to HubLinkstot.
e Pathstot is the number of paths with frequency ≥10%.
f Maximal length, i.e., excluding the two extreme amino acids, reached among paths
with frequency ≥10%.
g Maximal frequency reached among paths with frequency ≥10%.
h Number of paths with frequency ≥30%; the number in parenthesis is the
percentage with respect to Pathstot.
i Number of W246(6.48)-involving paths with frequency ≥30%; the number in
parenthesis is the percentage of such paths with respect to Paths30.
j Number of ZMA-involving paths with frequency ≥30%; the number in parenthesis
is the percentage of such paths with respect to Paths30.
k Number of paths with length≥5 and frequency≥30%; the number in parenthesis is
the percentage with respect to Paths30.
l Number of ZMA-mediated paths with length ≥5 and frequency ≥30%; the number
in parenthesis is the percentage of such paths with respect to Paths30-5.
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the PSN of free and ZMA-bound forms of monomeric A2AR.
Thenumber of hubs, i.e., nodes connected to at least four nodes in the
structure network, characterizing A2AR in at least 30% of the trajectory
frames is slightly higher for the MONOAPO and the three dimeric forms
compared to the MONO form (Tables 2 and 3). More than 25% of these
hubs are amino acids conserved inmore than 65% of family AGPCRs [43]
(i.e., underlined in Fig. 1 and Table 2). Such highly conserved and highly
connected amino acids includeN24(1.50) (theﬁrst number in parenthesis
refers to the helix and the following indicate the position of the helicalFig. 3. Representative paths inMONOAPO andMONO. Themost frequent paths with length≥5
Cα-atoms and connections between nodes are represented by green sticks. In those cases in
portion of the paths. To give a reference point within the structure, for each system the ﬁrst se
the following paths with their respective frequencies are shown: A) paths 20, (39.36%) and
MONO form, the following paths with their respective frequencies are shown D) paths 3 (
E) paths 17 (35.49%), 18 (35.48%), 19 (35.48%), 41 (30.52%) and 43 (30.23%); and F) pathsresidue relative to the most highly conserved residue within that helix,
here denoted as 50, according to the nomenclature proposed by
Ballesteros andWeinstein [44]), D52(2.50), F295(8.50) as well asmembers
of the DRY, FxxCWxP and NPxxYmotifs. Among these highly conserved
amino acids, those fromH2andH7 aswell asW246(6.48) inH6behave as
hubs in all the ﬁve simulated forms, suggestive of relevant structural/
functional roles (Table 2 and Supplementary Figs. 1–5 (Figs. S1–S5)).
Remarkably, theantagonist ZMA is themostpersistenthub, i.e., it is ahub
in 100% of the trajectory frames in all the four considered ligand–
receptor complexes (Table 2 and Figs. S1–S5). Moreover, ZMA is theare shown forMONOAPO, andMONO. Nodes are represented by spheres centered on the
which multiple paths are shown on the same structure, green sticks indicate the shared
t of paths is represented in the context of the receptor structure. For theMONOAPO form
72 (31.40%); B) paths 60 (32.46%) and 67 (31.68%); and C) path 78 (30.30%). For the
48.48%), 4 (48.47%), 5 (48.46%), 6 (42.31%), 8 (41.08%), 16 (36.09%) and 28 (33.70%);
37 (31.14%), 38 (31.14%) and 39 (31.12%).
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trajectory frames it is linked to at least 9 nodes (Table 2 and Figs. S1–S5).
For all the four ZMA-A2AR simulated complexes, themostpersistent links
of ZMA, i.e., present in more than 50% of frames, include F168 and E169
(both in EL2), M177(5.38), L249(6.51), H250(6.52), N253(6.55) and H264 (in
E3), which participate in the ZMA binding site in the crystallographic
complex [34]. In all the simulated forms, thehighly conservedW246(6.48)
appears to be a central hub in the connection between nodes in the
extracellular and intracellular ends of the helix bundle, whereas the
highly conserved D52(2.50), N280(7.45) and the members of the NPxxY
motif recur as hubs in the cytosolic halves of the network. Among the
highly conserved amino acids in the cytosolic end of the helix bundle,
N24(1.50) as well is a frequent hub in all simulated forms except DIM3
(Table 2).
The size, i.e., number of nodes and links, of the largest cluster, i.e., a set
of connected amino acids in the graph, is quite comparable for the ﬁve
simulated forms, beinggreater for the twomonomeric forms, inparticular
MONOAPO, compared to the three dimers (Table 3 and Figs. S1–S5). In this
respect, DIM1 holds less nodes and links than all the other systems
(Table 3). However, the three dimeric forms hold more hub-involving
links than the twomonomeric forms. This is particularly true if the ZMA-
bound monomer is considered (Table 3). The presence of the super-hub
ZMA, reduces the number of links in the extracellular half of the receptor
compared to the MONOAPO form (Figs. S1–S5). In spite of differences in
link frequencies (i.e., connecting line color) and strengths (i.e., connecting
linewidth), theway the antagonist ZMA is linked to the cytosolic domains
is quite similar for the MONO, DIM1 and DIM2 forms. Indeed, in all
three forms the L249(6.51)–S277(7.42) linked pair connects ZMA to the
W246(6.48)–N280(7.45)–D52(2.50)–N24(1.50) chain of highly conserved
amino acids, which are hubs in the PSG (Figs. S1–S5). The connection
between W246(6.48) and N280(7.45) can be also found mediated by
the highly conserved F242(6.44) that is a hub as well. On the other hand,
D52(2.50) can be also found connected to N284(7.49) that in turn is
connected to the Y288(7.53)–F295(8.50) pair, as in MONO and DIM1
(Figs. S2 and S3). For DIM2, the connection between N284(7.49) and the
Y288(7.53)–F295(8.50) pair is mediated by I238(6.40) (Fig. S4). Furthermore,
forMONO, DIM1 andDIM2, the node, N24(1.24), at the cytosolic extremity
of the network, is frequently found linked to P285(7.50) of the highly
conserved NPxxY motif (Figs. S2–S4). In the MONOAPO form, the link
between the conserved tryptophan in H6 and the N280(7.45)–N284(7.49)–
Y288(7.53) or N280(7.45)–D52(2.50)–N24(1.50) sequences is frequent aswell,
remarking the fundamental role of this amino acid in the structure
network of the A2AR (Fig. S1).
Different from all the other ZMA-complexed forms, in DIM3, the
S277(7.42)-mediated link between ZMA binding site and W246(6.48)
occurs in less than40% of frames.Moreover, the link betweenW246(6.48)
and N280(7.45) has a frequency lower than 50%. Taken all together, A2AR
structure graphs suggest that forMONO,DIM1andDIM2 theW246(6.48)-
mediated communication between ZMA binding site and highly
conserved amino acids in the cytosolic half of the network would
employ similar paths. Such communication is expected to be lower for
DIM3. Collectively, these data suggest for the H6–H6/H6–H7 type of
dimer a less marked coupling between extracellular nodes in the ligand
binding side and functionally relevant amino acids in the cytosolic
domains (Fig. S5).
Different from thehighly conserved amino acids in the cytosolic endof
H1 and H7, relevant connections between antagonist binding site and
R102(3.50), the fully conserved arginine of the E/DRYmotif at the cytosolicFig. 4. Representative paths in the targeted monomer of DIM1, DIM2 and DIM3. The most freq
following paths with their respective frequencies are shown: A) paths 15 (35.99%), 17 (35.
(32.03%), 30 (31.16%) and 37 (30.32%); and C) 24 (33.43), 25 (33.43%) and 26 (33.42%). Fo
(56.01%), 7 (56.00%), 8 (55.33%), 12 (51.99%), 14 (47.88%) and 20 (45.83%); E) 28 (42.14%),
(41.88%). 34 (40.39%), 43 (37.47%) and 53 (34.10%); and G) 59 (33.20%), 60 (33.19%) and 63
shown: H) paths 5 (54.61%) and 6 (53.93%); I) path 8 (41.35%); J) paths 13 (35.18%) and 15 (
description of this Figure.end of H3, are lacking in all the simulated forms (Figs. S1–S5).
Interestingly, R3.50 is engaged in a double salt bridge interaction with
the adjacent D101(3.49) andwith E228(6.30). It is worth noting that the link
between D101(3.49) and R102(3.50) is not reported in the PSG because PSN
analysis neglected all node pairs separated by less than two nodes (see
Methods). The link between R102(3.50) and E228(6.30) , which is absent in
the crystal structureusedas an input ofMDsimulations, occurs in≥90%of
frames for MONO, DIM1 and DIM2 (i.e., 99.18%, 98.78% and 99.74%,
respectively), in 54.93% of frames for DIM3, and in 36.30% of frames for
MONOAPO (Figs. S1–S5). In line with these data, the average interaction
strength between R3.50 and E6.30 is stronger in MONO, DIM1 and DIM2
compared to the other two forms (i.e., 3.62, 12.32, 11.43, 13.54 and 4.97
for MONOAPO, MONO, DIM1, DIM2 and DIM3, respectively).
3.2.2. Analysis of communication paths
For each of the ﬁve considered systems, path search collected all
the shortest paths between each considered node-pair (see Methods)
with frequency ≥10% and with a length ≥3, i.e., excluding the two
extremities. The following analysis of path composition will focus on
paths with frequencies≥30% and length≥5 (Supplementary Tables 1
and 5 (Tables S1–S5)). Length cutoff serves to focus on paths with the
extremities located as much as possible at the two poles of the helix
bundle. In this respect, the highest length of 15 was achieved by DIM1
(Table 3).
In the MONOAPO form, the most frequent paths with the two
extremities at the two poles of the helix bundle involve H1, H2 and H7
amino acids. Indeed, the extracellular extremity lays on H1 or H2,
whereas the cytosolic end involves amino acids in theNPxxYmotif and/
or N24(1.50) (Table S1). Other frequent paths share either W246(6.48)–
N280(7.45)–N284(7.49)–Y288(7.53) or W246(6.48)–F242(6.44)–N280(7.45)–
N284(7.49) stretches of highly conserved amino acids and do not extend
much to the extracellular extremity of the bundle, i.e., the majority of
these paths share W246(6.48) as the extracellular extremity (Table S1).
Antagonist binding reduces signiﬁcantly the total number of paths
compared to the ligand-free monomeric form (i.e., 840 and 579,
respectively, for the MONOAPO and MONO forms, Table 3). Reduction
in the number of different paths following ZMA binding is likely
linked to the super-hub behavior of the antagonist that limits the
extracellular nodes of the paths to its interaction partners (Figs S1–S5,
Tables S1 and S2).
A2AR dimerization causes as well changes in the communication
paths found in the isolated monomer in complex with ZMA (Table 3
and S2–S5). Depending upon the dimer architecture, dimerization
increases, for DIM1 and DIM2, or decreases, for DIM3, the number of
paths compared to the MONO form (Table 3). The longest path length
at frequencies ≥10% for MONOAPO, MONO, DIM1, DIM2 and DIM3 is
12, 11, 15, 12 and 9, respectively (Table 3).
The composition of most recurrent paths in the MONO, DIM1 and
DIM2 forms is similar, being characterized by the presence in each path of
at least four highly conserved amino acids, which are also hubs. In this
respect, the conserved amino acids that occur the most in such paths
include N24(1.50), D52(2.50), F242(6.44), W246(6.48), N280(7.45) and
the members of the NPxxY motif in H7, i.e., N284(7.49), P285(7.50) and
Y288(7.53) (Tables S2–S4). For these three forms, N70% of paths with
frequencies ≥30% and lengths ≥5 hold ZMA as a node in their
extracellular half. In detail, MONO, DIM1 and DIM2 share sets of paths
differing for the amino acid connected with the antagonist (i.e., F168,
E169, M177(5.38) H250(6.52), N253(6.55), and H264 (in E3); Tables S1–S4).uent paths with length≥5 are shown for DIM1, DIM2 and DIM3. For the DIM1 form the
96%), 27 (32.82%), 29 (31.90%) and 32 (30.97%); B) paths 21 (35.15%), 22 (35.12%), 28
r the DIM2 form the following paths with their respective frequencies are shown: D) 6
29 (42.12%), 32 (41.75%), 38 (38.76%) and 47 (35.64%); F) 25 (42.43%), 26 (42.43%), 31
(32.99%). For the DIM3 form the following paths with their respective frequencies are
34.48%); and K) paths 14 (35.07%) and 16 (32.31%). See the legend to Fig. 3 for a general
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W246(6.48)–N280(7.45)–D52(2.50)–N24(1.50), or ZMA–L249(6.51)–S277(7.42)–
W246(6.48)–N280(7.45)–D52(2.50)–N24(1.50)–P285(7.50) or ZMA–L249(6.51)–
S277(7.42)–W246(6.48)–N280(7.45)–D52(2.50)–N284(7.49)–Y288(7.53) or
ZMA–L249(6.51)–S277(7.42)–W246(6.48)–N280(7.45)–D52(2.50)–N284(7.49)
sequences, include the highly conserved W246(6.48) in the middle and
N24(1.50) or a member of the NPxxY motif at the cytosolic end (Tables
S2–S4 andFigs. 3 and4). Remarkably, the conserved tryptophanacts as a
linker between extracellular and intracellular halves in almost all
recurrent paths (i.e., 90.91%, 91.89% and 89.89%, for the MONO, DIM1
and DIM2, respectively, Table 3), suggesting the presence of a diffuse
W246(6.48)-mediated communication between antagonist binding site
and highly conserved amino acids at the cytosolic ends of H1 or H7
(Tables S2–S4 and Figs. 3 and 4). In this respect, the most diffuse
communication concerns DIM2.
DIM3 differs signiﬁcantly from the other three ZMA-bound forms in
that ZMA is never found as a node in paths with frequency ≥30%
(Tables 3 and S5). On the same line, the weight of W246(6.48) is
signiﬁcantly lower compared to the other simulated forms, as it occurs
in only 21% of paths (Tables 3 and S5). Finally, path length tends on
average to be short such that the most recurrent paths that share the
C245(6.47)–N280(7.45)–D52(2.50)–Y288(7.53) amino acid stretch localize
almost entirely in the cytosolic half of the receptor. (Fig. 4, Table S5).
Taken as awhole, the results of path analysis show that paths that are
intrinsic to the topology of theA2AR, i.e., inferred from theMONOAPO form,
share a higher contribution of H1 and H2 compared to the ZMA-bound
forms, for which the contribution of H6 is higher compared to the APO-
form (Fig. 5). Finally, DIM3 is characterized by the highest contribution of
H3 and the lowest contribution of H7 among all the simulated systems.
Overall, path composition concerning the targeted monomer in
the H6–H6/H6–H7 dimer is signiﬁcantly different from that of the
same monomer simulated alone (i.e., MONO) or in the H1–H1/H2–H2
(i.e., DIM1) and H1–H4/H2–H2 (i.e., DIM2) dimer architectures.
Indeed, the DIM1 and DIM2 architectures seem to enhance, whereas
the DIM3 architecture reduces the ZMA-mediated communications
between ligand binding site and cytosolic regions, compared to the
isolated monomer. Consistent with the functional effect of the ZMA
antagonist, in neither one of the simulated ZMA-receptor complexesFig. 5. Helix contribution to the communication paths. The average number of residues cont
been obtained by dividing the total number of amino acids contributed by each receptor po
DIM2 and DIM3 forms are indicated, respectively, by blue, red, yellow, green and violet histhe antagonist binding site is coupled to the neighborhoods of the E/
DRY arginine deputed to G protein recognition and activation.
4. Discussion
GPCRs are allosteric proteins whose functioning fundamentals are
the communication between the two poles of the helix bundle, i.e., the
extracellular side receives and transfers extracellular signals to the
intracellular side deputed to recognize and activate the G protein
transducer. Functionally different ligands like agonists, inverse agonists
and antagonists aswell as different homo- andhetero-oligomeric states,
i.e., from dimer to higher-order oligomer, are likely to exert differential
impacts on such communication.
The representation of GPCR structures as networks of interacting
amino acids can be a meaningful way to decipher the impact of ligand
and dimerization/oligomerization on the molecular communication
intrinsic to the protein fold, which is likely to serve to protein stability
and function. In this study, the crystallographic structure of the A2AR
simulated in its empty and antagonist-bound monomeric and dimeric
forms has been investigated in terms of information processing
networks, in which privileged residues are deputed to receive and
propagate information. The dynamic network of intramolecular inter-
actions, i.e., inferred fromMD trajectories, characterizing theA2AR–ZMA
complex in its monomeric state (MONO) has been compared with that
of the same complex in three different dimeric forms (DIM1, DIM2 and
DIM3), as well as with that of the apo-monomer (MONOAPO).
Taken as awhole, the results of this investigation emphasize the role
of highly conserved amino acids inH1,H2,H6andH7 inmaintaining the
structure network of the A2AR through their persistent hub behavior, in
line with a very recent study on rhodopsin [45]. Consistently, such
amino acids participate in the cytosolic halves of the most frequent
paths, suggesting a fundamental role in the information ﬂow between
the twopoles of thehelix bundle. Collectively, these inferences are likely
to apply to the homologous GPCRs given the signiﬁcant structural
similarities among them [46–49]. The most frequent communication
paths donot include the E/DRYmotif in the cytosolic extension of H3, an
important receptor recognition portion for theG protein [50,51]. Lack of
communication between antagonist and G protein binding sites is likelyributed by each receptor portion to the shortest communication paths is plotted. It has
rtion by the total number of paths with frequency ≥10. The MONOAPO, MONO, DIM1,
tograms.
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depend on whether the simulated ligand–receptor complex is in
monomeric or dimeric forms. The inactive state features of the
simulated complexes are strengthened by the observation that they
all share interactions between R3.50 and both D3.49 and E6.30, similar
to the crystal structure of dark rhodopsin [49], the intra-helical
interaction being stronger and more persistent than the inter-helical
one. Based on such consensus from different MD simulations, we
suggest that the lack of the R3.50-E6.30 interaction in the crystal
structure is either due to an artifact, like for example the presence of T4-
lysozyme, or represents one of the possible inactive states of the
receptor. On the other hand, such inter-helical salt bridge may be a
feature of selected inactive states of the A2AR, similar to rhodopsin and
other homologous GPCRs [49,52].Collectively, the study highlights
distinctive structural/functional roles for the DRY motif and the highly
conserved amino acids in the cytosolic ends of H1, H2 and H7.
The results of this study emphasize the role of H1 in mediating
A2AR dimerization as two out of the three predicted dimers share H1
at the inter-monomer interface. This is consistent with emerging
evidence from structure determinations, structure predictions and in
vitro experiments [20–26]. Moreover, the H1–H1/H2–H2 and H1–H4/
H2–H2 dimers retain the typology of the most frequent communica-
tion paths seen in the complexed form of themonomer, but increasing
signiﬁcantly the number of hub-involving links and paths compared
to the MONO form. In this respect, the H1–H4/H2–H2 architecture
shows the most diffuse communication among all the ZMA-
complexed forms. In contrast, the H6–H6/H6–H7 dimer is suggested
to impair ligand-mediated communication, as it is characterized by a
dramatic reduction in the total number of paths compared to the
MONO form and by the complete loss of ZMA-involving paths at
frequencies ≥30%. The impairing effect of DIM3 architecture is
expected to be even more marked for the agonist-bound forms, for
which such dimer architecture would hinder H6 movements required
for receptor activation [26].
In conclusion A2AR dimerization affects the communication net-
works intrinsic to the receptor fold in a way dependent on the dimer
architecture. Certain architectures retain the most recurrent commu-
nication paths with respect to the monomeric antagonist-bound form
but enhancing path numbers and frequencies, whereas some others
impair ligand-mediated communication networks. Ligand binding
affects the network as well. Overall the communication network that
pertains to the functional dynamics of a GPCR is expected to be
inﬂuenced by ligand functionality, oligomeric order and architecture
of the supramolecular assembly.
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